230 related articles for article (PubMed ID: 10965926)
1. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
Neumann S; Claus M; Paschke R
Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Sep; 144(9):3821-7. PubMed ID: 12933653
[TBL] [Abstract][Full Text] [Related]
5. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
Hamidi S; Chen CR; McLachlan SM; Rapoport B
Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
[TBL] [Abstract][Full Text] [Related]
6. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
Lado-Abeal J; Quisenberry LR; Castro-Piedras I
Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
[TBL] [Abstract][Full Text] [Related]
7. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
9. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
11. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
Jaeschke H; Schaarschmidt J; Günther R; Mueller S
Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
[TBL] [Abstract][Full Text] [Related]
12. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.
Schaarschmidt J; Nagel MBM; Huth S; Jaeschke H; Moretti R; Hintze V; von Bergen M; Kalkhof S; Meiler J; Paschke R
J Biol Chem; 2016 Jul; 291(27):14095-14108. PubMed ID: 27129207
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain.
Chen CR; McLachlan SM; Rapoport B
J Biol Chem; 2011 Feb; 286(8):6219-24. PubMed ID: 21190937
[TBL] [Abstract][Full Text] [Related]
17. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
[TBL] [Abstract][Full Text] [Related]
18. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
19. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
20. Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells.
Chen CR; Salazar LM; McLachlan SM; Rapoport B
Endocrinology; 2015 Jul; 156(7):2732-8. PubMed ID: 25860033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
